Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

1.20
Delayed Data
As of 1:04pm ET
 +0.04 / +3.45%
Today’s Change
0.80
Today|||52-Week Range
3.43
-19.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues5.7M4.1M47.8M5.6M
 
 
 
 
 
Cost of Goods Sold----7.9M12.5M
 
 
 
Depreciation And Amortization4.4M4.3M3.3M3.4M
 
 
 
 
 
 
Operating ExpensesGross Income----36.6M-10.4M
 
 
 
General Expenses35.6M27.2M34.9M27.1M
 
 
 
 
 
Research And Development28.3M21.8M19.1M13.7M
 
 
 
 
 
Total Operating Expenses40.0M31.5M46.1M43.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.4M-27.5M1.8M-37.5M
 
 
 
 
 
Extraordinary Credit0.00479.0K0.008.1M
 
 
 
Extraordinary Charge-4.0M0.00-39.9M--
 
 
 
Interest Expense On Debt2.2M1.4M1.5M7.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-40.5M-28.0M-39.6M-36.7M
 
 
 
 
 
Net Income-40.5M-28.0M-39.6M-36.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.8M12.5M16.7M17.8M
 
 
 
 
 
Shares To Calculate EPS Diluted6.8M12.5M16.7M17.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.00-$2.24-$2.38-$2.07
 
 
 
 
 
EPS Diluted-$6.00-$2.24-$2.38-$2.07